Novel Research Shows the Value of Echo with UEAs in Complex CHD Patients

Echocardiography (heart ultrasound) with ultrasound enhancing agents (UEAs) has proven to be a valuable imaging procedure after surgery for children born with single ventricle congenital heart disease (CHD). This heart defect occurs when one of the two pumping chambers in the heart, called ventricles, is not large enough or strong enough to work correctly. Research being presented at the ASE 2021 Scientific Sessions Virtual Experience, June 18-21, 2021, highlights how echocardiography with UEAs (agents that do not involve radiation) in CHD patients postoperatively can improve diagnostic capabilities and decrease the need for additional testing. Read more here.